报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 12.51% | -59.82% | -24.58% | 147/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 16.59% | -50.17% | -8.82% | 144/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 18.19% | 2% | -35.58% | 139/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 28.24% | -3.88% | -9.29% | 125/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 31.13% | 2% | -6.47% | 120/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 33.28% | 12.33% | 13.3% | 116/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
2022-12-31 | 29.37% | -14.94% | -0.86% | 122/160 | 53.57% | 迈威生物 | 99.46% | 行业排名> |
2022-06-30 | 29.63% | -31.67% | -14.21% | 120/160 | 21.79% | 迈威生物 | 99.75% | 行业排名> |
2021-12-31 | 34.53% | -18.58% | -18.58% | 121/160 | 55.07% | 迈威生物 | 99.67% | 行业排名> |
2020-12-31 | 42.41% | 10.95% | 10.95% | 102/160 | -143.08% | 迈威生物 | 99.44% | 行业排名> |
2019-12-31 | 38.23% | 2% | -11.83% | 104/160 | -1204.25% | 迈威生物 | 98.57% | 行业排名> |
2019-06-30 | 43.36% | 2% | 2% | 77/160 | 55.36% | 首药控股 | 99.93% | 行业排名> |